Without checking the historical data, it appears there is some seasonality to orders being placed in either half of the financial year (which is weird for medical products).
My take is that the co. expects a strong FY result despite the second half generally being weaker.
I think the report you have read is being conservative.
Without checking the historical data, it appears there is some...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
